**Equity Swap Contract**

This contract is an equity swap between Party A (Party1) and Party B (Party2). The trade date is September 24, 2001, and the effective date is the same as the trade date.

**Trade Details**

* Trade Identifier: 6234 (Party A) and 6569 (Party B)
* Global Key: 9593cc32 (Party A) and 95944c36 (Party B)
* Trade Date: September 24, 2001
* Trade Lot: The contract is for a single trade lot.

**Counterparties**

* Party A (Party1): Party A is the buyer of the equity swap.
* Party B (Party2): Party B is the seller of the equity swap.

**Contractual Terms**

* Product: The contract is an equity swap with a single-name underlying.
* Product Taxonomy: The contract is classified as an Equity:Swap:PriceReturnBasicPerformance:SingleName.
* Economic Terms:
	+ Effective Date: The effective date is three business days after the trade date.
	+ Termination Date: The termination date is the same as the effective date.
	+ Payout: The contract has an interest rate payout and a performance payout.
	+ Interest Rate Payout: The interest rate payout is based on the USD LIBOR-BBA rate.
	+ Performance Payout: The performance payout is based on the total return of the underlying security.
* Calculation Agent: The calculation agent is Party A (Party1).
* Governing Law: The governing law is English.

**Underlying Security**

* Security Type: The underlying security is an equity security.
* Product Identifier: The product identifier is SHPGY.O and Shire Pharmaceuticals Group - American Depositary Receipts.
* Return Terms: The return terms are based on the total return of the underlying security.

**Payment Terms**

* Party A Payments: Party A pays the interest rate payout to Party B.
* Party B Payments: Party B pays the performance payout to Party A.
* Payment Dates: The payment dates are annually two business days after the effective date.

**Risk Disclosure**

* The contract carries significant risks, including foreign exchange risk, price risk, liquidity risk, and credit risk.
* Party B should consult its own financial, legal, accounting, and tax advisors about the risks associated with the contract.

**Scenario Analysis**

* The scenario analysis assumes various levels of USD SOFR-COMPOUND and shows the resultant cash flow gain/loss to Party B.

**Mark to Market (MTM) Sensitivity Analysis**

* The MTM sensitivity analysis shows the changes in the MTM due to parallel shifts in the USD SOFR-COMPOUND curve.

**Level of Pricing Variables and Impact of Variables on Pricing**

* The level of pricing variables and impact of variables on pricing are provided for information purposes only.

**Representations**

* Each party represents to the other party that it is acting for its own account and has made its own independent decisions to enter into the contract.

**Acceptance and Agreement**

* The contract is accepted and agreed upon by Party B (Party2).